HIF-dependent induction of adenosine A2B receptor in hypoxia

被引:271
作者
Kong, Tianqing
Westerman, Karen A.
Faigle, Marion
Eltzschig, Holger K.
Colgan, Sean P.
机构
[1] Univ Colorado, Hlth Sci Ctr, Mucosal Inflammat Program, Denver, CO 80262 USA
[2] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Expt Therapeut, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA
关键词
hypoxia-inducible factor; endothelium; chromatin; angiogenesis;
D O I
10.1096/fj.06-6419com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adenosine has been widely associated with hypoxia of many origins, including those associated with inflammation and tumorogenesis. A number of recent studies have implicated metabolic control of adenosine generation at sites of tissue hypoxia. Here, we examine adenosine receptor control and amplification of signaling through transcriptional regulation of endothelial and epithelial adenosine receptors. Initial studies confirmed previous findings indicating selective induction of human adenosine A2B receptor (A2BR) by hypoxia. Analysis of the cloned human A2BR promoter identified a functional hypoxia-responsive region, including a functional binding site for hypoxia-inducible factor (HIF) within the A2BR promoter. Further studies examining HIF-1 alpha DNA binding and HIF-1 alpha gain and loss of function confirmed strong dependence of A2BR induction by HIF-1 alpha in vitro and in vivo mouse models. Additional studies in endothelia overexpressing full-length A2BR revealed functional phenotypes of increased barrier function and enhanced angiogenesis. Taken together, these results demonstrate transcriptional coordination of A2BR by HIF-1 alpha and amplified adenosine signaling during hypoxia. These findings may provide an important link between hypoxia and metabolic conditions associated with inflammation and angiogenesis.
引用
收藏
页码:2242 / 2250
页数:9
相关论文
共 42 条
[1]   Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release [J].
Decking, UKM ;
Schlieper, G ;
Kroll, K ;
Schrader, J .
CIRCULATION RESEARCH, 1997, 81 (02) :154-164
[2]   Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1 [J].
Desai, A ;
Victor-Vega, C ;
Gadangi, S ;
Montesinos, MC ;
Chu, CC ;
Cronstein, BN .
MOLECULAR PHARMACOLOGY, 2005, 67 (05) :1406-1413
[3]   HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia [J].
Eltzschig, HK ;
Abdulla, P ;
Hoffman, E ;
Hamilton, KE ;
Daniels, D ;
Schönfeld, C ;
Löffler, M ;
Reyes, G ;
Duszenko, M ;
Karhausen, J ;
Robinson, A ;
Westerman, KA ;
Coe, IR ;
Colgan, SP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (11) :1493-1505
[4]   Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium:: Role of ectonucleotidases and adenosine A2B receptors [J].
Eltzschig, HK ;
Ibla, JC ;
Furuta, GT ;
Leonard, MO ;
Jacobson, KA ;
Enjyoji, K ;
Robson, SC ;
Colgan, SP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :783-796
[5]   Differential expression of adenosine receptors in human endothelial cells -: Role of A2B receptors in angiogenic factor regulation [J].
Feoktistov, I ;
Goldstein, AE ;
Ryzhov, S ;
Zeng, DW ;
Belardinelli, L ;
Voyno-Yasenetskaya, T ;
Biaggioni, I .
CIRCULATION RESEARCH, 2002, 90 (05) :531-538
[6]   Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype [J].
Feoktistov, I ;
Ryzhov, S ;
Zhong, HY ;
Goldstein, AE ;
Matafonov, A ;
Zeng, DW ;
Biaggioni, I .
HYPERTENSION, 2004, 44 (05) :649-654
[7]   A3 adenosine receptor as a target for cancer therapy [J].
Fishman, P ;
Bar-Yehuda, S ;
Madi, L ;
Cohn, I .
ANTI-CANCER DRUGS, 2002, 13 (05) :437-443
[8]   Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia [J].
Furuta, GT ;
Turner, JR ;
Taylor, CT ;
Hershberg, RM ;
Comerford, K ;
Narravula, S ;
Podolsky, DK ;
Colgan, SP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (09) :1027-1034
[9]   Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease [J].
Giatromanolaki, A ;
Sivridis, E ;
Maltezos, E ;
Papazoglou, D ;
Simopoulos, C ;
Gatter, KC ;
Harris, AL ;
Koukourakis, MI .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (03) :209-213
[10]   The identification of the adenosine A2B receptor as a novel therapeutic target in asthma [J].
Holgate, ST .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (08) :1009-1015